COPD alternative treatment

[Guest guest]

http://www.raysahelian.com/copd.html

 

COPD alternative treatment, vitamins herbs and supplements by Ray Sahelian, M.D. Natural therapy for Chronic Obstructive Pulmonary Disease

COPD is a group of serious lung diseases that includes emphysema and chronic bronchitis. COPD is a leading cause of morbidity and mortality worldwide. COPD)= is the fourth leading cause of death in the United States. Its epidemiology has changed over the years and the key changes are a rising mortality rate and a greater incidence among women. COPD is typically considered a disease due to cigarette smoking, however COPD can also occur in non smokers. Worldwide, up to 10 percent of adults aged 40 and older have lung impairment consistent with chronic obstructive pulmonary disease, or COPD. As expected, COPD is more common in smokers, males, older adults, and persons living in urban areas.

 

COPD naturat treatment, alternatives to medicationResearch regarding the use of natural supplements to treat COPD is quite early, so no confident statements can be made at this time, but antioxidants and the following nutrients and herbs could be considered:Creatine may help with muscle strength and endurance.Ginseng in very low dosagesOmega- 3 fatty acids can be anti-inflammatory agents. Japanese researchers at Kagoshima University Hospital found that supplements of omega-3 fatty acids appeared to improve patients' breathing difficulties -- possibly by countering the airway inflammation seen in those with COPD. Omega-3 polyunsaturated fatty acids are found largely in oily fish, and to a lesser extent in flaxseed, walnuts, soybeans and canola oil. Half of the 64 patients drank a liquid supplement rich in omega-3 fats each day; the other half drank a supplement containing omega-6 fats, another type of polyunsaturated fat found in many foods, including vegetable oils and meat. After two years, patients in the omega-3 supplement group showed an overall improvement on tests that measured their breathing during a short bout of exercise. Glutamine is an amino acid that may help some individuals with COPD. You can purchase Glutamine supplement here.BCAA supplements could be helpful for protein synthesis. You can purchase BCAA supplements over the counter.

Antioxidants and COPDAntioxidant therapeutic targets in COPD.Curr Drug Targets. 2006 Jun;7(6):707-20. Rahman I, Kilty I. Department of Environmental Medicine, Division of Lung Biology and Disease, University of Rochester Medical Center, 601 Elmwood Ave., Box 850, Rochester, NY.Oxidative stress and chronic inflammation are important features in the pathogenesis of chronic obstructive pulmonary disease ( COPD ). Oxidative stress has important consequences for several elements of lung physiology and for the pathogenesis of COPD, including oxidative inactivation of antiproteases and surfactants, mucus hypersecretion, membrane lipid peroxidation, alveolar epithelial injury, remodeling of extracellular matrix, and apoptosis. Therefore, targeting oxidative stress with antioxidants or boosting the endogenous levels of antioxidants is likely to be beneficial in the treatment of COPD. Antioxidant and/or anti-inflammatory agents such as thiol molecules (glutathione and mucolytic drugs, such as N-acetyl-L-cysteine and N-acystelyn), dietary polyphenol (curcumin -diferuloylmethane, a principal component of turmeric), resveratrol (a flavanoid found in red wine), green tea (theophylline and epigallocatechin-3- gallate), ergothioneine (xanthine and peroxynitrite inhibitor), quercetin, erdosteine and carbocysteine lysine salt, have been reported to control NF-kappaB activation, regulation of glutathione biosynthesis genes, chromatin remodeling and hence inflammatory gene expression. Since a variety of oxidants, free radicals and aldehydes are implicated in the pathogenesis of COPD it is possible that therapeutic administration of multiple antioxidants will be effective in the treatment of COPD.

Soy foodsDr. Andy H. Lee of the Curtin University of Technology, Perth, Australia, studied 278 COPD patients (244 men and 34 women) between the ages of 50 and 75 years who were diagnosed within the past 4 years. They also recruited 340 people (272 men and 68 women) without the disease. Control subjects consumed more soy per day (about 60 grams) than patients with COPD (about 45 grams). Dr. Andy H. Lee says the risk of COPD was significantly reduced among those who ate more soy. Similar decreases in the risk of COPD were observed with higher intakes of tofu and bean sprouts. The more soy people consumed, the fewer breathing problems they had, particularly breathlessness. Respiratory Research, June 26, 2009.

Nitrates makes COPD worseMen who smoke increase their risk of developing COPD, emphysema and chronic bronchitis if they eat lots of cured meat. Cured meats such as sausage, ham, bologna, bacon and hot dogs contain high levels of nitrites, which are added to prevent rancidity and bacterial growth and enhance a meat's pink color. And just like cigarette smoking and air pollution, nitrites generate molecules known as reactive oxygen and nitrogen species that have been linked to COPD. American Journal of Epidemiology, December 15, 2007.

COPD Natural Treatment Research Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease.Thorax. 2005 Jul;60(7):531-7.Skeletal muscle wasting and dysfunction are strong independent predictors of mortality in patients with chronic obstructive pulmonary disease (COPD). Creatine nutritional supplementation produces increased muscle mass and exercise performance in health. A controlled study was performed to look for similar effects in 38 patients with COPD. Creatine supplementation led to increases in fat-free mass, peripheral muscle strength and endurance, health status, but not exercise capacity. Creatine may constitute a new ergogenic treatment in COPD.

Ginseng improves pulmonary functions and exercise capacity in patients with COPD.Arch Chest Dis. 2002 Oct-Dec;57(5-6):242-6.Ginseng is a root that has been used to treat patients with various illnesses for the last 2000 years. The purpose of this study was to evaluate the effects of Ginseng extract (G115) on Pulmonary Function Tests (PFTs), Maximum Voluntary Ventilation (MVV), Maximum Inspiratory Pressure (MIP) and Maximal Oxygen Consumption (VO2max) in patients with moderately-severe Chronic Obstructive Pulmonary Disease ( COPD ). Results: Ginseng 100 mg bid for three months, but not placebo, improved PFTs, MVV, MIP and VO2 max in patients with moderately-severe COPD with no side effects.

COPD and Glutamine, GlutamateLow plasma glutamate and glutamine concentrations are often seen in chronic obstructive pulmonary disease (COPD). Glutamine or glutamate supplementation may be a good option for preventing further metabolic disturbances in COPD patients. However, the metabolic effects of glutamate supplementation have never been compared with those of glutamine supplementation. In a new study, repeated ingestion of glutamine and glutamate resulted in different effects on the plasma amino acid concentration. In both groups, ingestion of glutamine but not of glutamate increased the plasma concentrations of citrulline and arginine, substrates produced in the intestine and the liver.

Omega-3 helpful in COPDJapanese researchers at Kagoshima University Hospital found that supplements of omega-3 fatty acids appeared to improve patients' breathing difficulties -- possibly by countering the airway inflammation seen in the disease. Omega-3 polyunsaturated fatty acids are found largely in oily fish, and to a lesser extent in flaxseed, walnuts, soybeans and canola oil. Half of the 64 patients drank a liquid supplement rich in omega-3 fats each day; the other half drank a supplement containing omega-6 fats, another type of polyunsaturated fat found in many foods, including vegetable oils and meat. After two years, patients in the omega-3 supplement group showed an overall improvement on tests that measured their breathing during a short bout of exercise.

Weight trainingPeople with chronic lung disease like emphysema or bronchitis can strengthen their arms and legs with resistance training, and this strength may help them perform everyday tasks more easily. CHEST, November 2009.

COPD and Weight LossAmong people with chronic obstructive pulmonary disease (COPD), usually emphysema, a low fat-free body mass index appears to be associated with greater mortality. There is a clear association between decreasing body mass index (BMI) and mortality both in the general population and in those with COPD. Fat mass is a metabolic inactive energy source, but fat-free mass contains the metabolic active organs, skeletal muscle being the largest of these organs.

COPD and depressionPatients with chronic obstructive pulmonary disease COPD who suffer from depression have shorter survival times, suggesting that antidepressant medication, or natural antidepressants, or psychological interventions may improve their outcomes. Natural antidepressants such as low doses of 5-HTP or St. John's wort, are worth a try. Depression is more common in patients with COPD than in the general population.

COPD pathophysiologyCOPD primarily affects the distal airways. As a rule, inflammation affects bronchioles at the level of the respiratory bronchiole extending to the alveolar wall.Airway walls are infiltrated with macrophages and lymphocytes. In contrast to asthma, the airway lymphocytes tend to be CD8+ rather than CD4+ cells. The CD4+ cells that are present in COPD tend to be Th1 rather than the Th2 cells found in asthma. Neutrophils are found in greater numbers in the airway lumen, and peribronchiolar fibrosis is seen in mid- to late-stage disease. Affected airways tend to be < 2 mm in diameter; airway obstruction results from structural narrowing caused by the inflammatory process, loss of elastic recoil due to breakdown of intra-alveolar elastic fibers, and loss of alveolar attachments from emphysema-induced alveolar septal destruction.

COPD and particle Inhalation The pathogenesis of COPD mirrors a chronic inhalational dust-induced disease. The inorganic dust in cigarette smoke is aluminum silicate or kaolinite, a common component of clay soils. Kaolinite has been recovered in the alveolar macrophages of smokers and has been reported as a constituent of tobacco products. On inhalation, kaolinite deposition in the distal lung may promote macrophage accumulation within the terminal airways leading to a respiratory bronchiolitis. In the susceptible smoker, important genetic, environmental, immunologic, and mechanical factors interact and modulate this small airway inflammation, ultimately leading to the pathologic lesion of emphysema. End stage COPD - surgeryAt some point in time, many patients with end-stage COPD require intubation and mechanical ventilation to sustain life. COPD surgery is available. A type of operation called lung volume reduction surgery (LVRS) can provide lasting benefits for people with COPD, including improvements in exercise ability, quality of life, and survival. COPD is a disease closely associated with smoking, involves the destruction of the tiny air sacs in the lungs where oxygen is exchanged for carbon dioxide. LVRS works by removing the diseased portions of the lung, making the whole organ function better. LVRS, however, is not for everyone with emphysema. People with COPD in the upper portions of the lung who have low exercise capacity seem to glean the most benefit from the operation. COPD ExacerbationSteroids do improve several outcomes during an acute COPD exacerbation, and a 10- to 14-day course seems appropriate, but not long term use. In people who suffer from COPD, adding an inhaled steroid to a so-called "long-acting beta-2 agonist" may do more harm than good. The benefit of the two-drug approach in COPD is limited, and furthermore, it's accompanied by substantial risks of pneumonia and other infection. Chest, October 2009.

Antibiotic use has been shown to be beneficial, especially for patients with severe exacerbation. Changes in bacteria strains have been documented during exacerbations, and newer generations of antibiotics might offer a better response rate. There is no role for mucolytic agents or chest physiotherapy in the acute exacerbation setting. Noninvasive positive pressure ventilation might benefit a group of patients with rapid decline in respiratory function and gas exchange.Asthma and COPD

What are the symptoms of COPD?Cough is usually the first COPD symptom to develop. It is productive with phlegm (sputum). It tends to come and go at first, and then gradually becomes more persistent (chronic). Breathlessness ('short of breath') and wheeze may occur only when you exert yourself at first (for example, when you climb stairs). These symptoms tend to become gradually worse over the years if you continue to smoke. The damaged airways make a lot more mucus than normal. This forms sputum (phlegm). Wheezing with cough and breathlessness may become worse than usual if you have a chest infection. Sputum usually turns yellow or green during a chest infection.

COPD Drug TreatmentAdvair does not have a significant effect on survival rates in patients with chronic obstruction pulmonary disorder (COPD). Advair is made by the drugmaker GlaxoSmithKline. A combination of two GlaxoSmithKline drugs may help keep patients with chronic obstructive pulmonary disease (COPD) from suffering severe complications. The company already reported that the combination -- known as Advair in the United States, Viana in Germany and Seretide in the rest of the European Union -- did not significantly cut the rate of death in COPD patients. Advair contains a combination of fluticasone and salmeterol.

COPD and steroid inhaler treatmentInhaled corticosteroid therapy can temporarily improve lung function in patients with chronic obstructive pulmonary disease (COPD), but after several months the decline in lung function resumes. Therefore, the long term benefit of inhaled steroid use by COPD patients is questioned. People with chronic obstructive pulmonary disease are more likely to get pneumonia if they use inhaled corticosteroid drugs.

Cough and COPDIn adults between 20 and 44 years of age, the presence of chronic cough and phlegm greatly increases the risk of COPD, even after adjusting for smoking. The presence of chronic cough and phlegm is not an innocent symptom, but is an early marker of airflow obstruction. American Journal Respiratory Critical Care Medicine 2007;175:32-39.

Smoking damages lung of women more than menWomen seem to be more susceptible to the harmful effects of smoking than their male counterparts. Dr. Inga-Cecilie Soerheim, from the University of Bergen, Norway has found that women are more susceptible to smoking-related lung damage and experience reduced lung function at an earlier age or after less smoking exposure than men. Dr. Inga-Cecilie Soerheim studied 954 subjects with moderate or severe COPD and 955 controls. All of the subjects were either current or former smokers. Women had worse lung function and more severe disease than men in subgroups with early-onset COPD (<60 years of age) and low smoking exposure COPD (<20 cigarettes/day for <20 years).

COPD natural treatment questionsQ. Hello; have you heard of anybody prescribing pregnenalone for COPD. . chronic obstructive pulmonary disease ? A. No we have not. We would be quite cautious in using pregnenolone for COPD since most people get COPD from smoking, and smoking damages heart tissue which makes it prone to palpitations. Pregnenolone can aggravate heart rhythm problems.

Q. I have COPD and have been taking flaxseed for the last 2 weeks and it may all be in my mind but I swear that my breathing has greatly improved. Can flaxseed be of benefit to COPD patients? I keep very active but generally run out of breath easily. This week I have been able to do so many things without being completely out of breath. The only thing I am doing differently is putting 1 tablespoon of ground flaxeed in my oatmeal. Have studies ever been made on the benefit of flaxseed on lung disease patients? A. We have not seen specific studies with flaxseed and COPD, but it could be possible since flaxseed has some anti-inflammatory properties.

Essential fatty acids in health and chronic disease.Am J Clin Nutr. 1999 Sep. Simopoulos AP. Center for Genetics, Nutrition and Health, Washington, DC 20009 Human beings evolved consuming a diet that contained about equal amounts of n-3 and n-6 essential fatty acids. Over the past 100-150 y there has been an enormous increase in the consumption of n-6 fatty acids due to the increased intake of vegetable oils from corn, sunflower seeds, safflower seeds, cottonseed, and soybeans. Today, in Western diets, the ratio of n-6 to n-3 fatty acids ranges from approximately 20-30:1 instead of the traditional range of 1-2:1. Beneficial effects of n-3 fatty acids have been shown in the secondary prevention of coronary heart disease, hypertension, type 2 diabetes, and, in some patients with renal disease, rheumatoid arthritis, ulcerative colitis, Crohn disease, and chronic obstructive pulmonary disease.

Q. I am 55 and a few years ago I was diagnosed with COPD. I recently read an article about the benefits of inhaled Glutathione. Is this inhaled glutathione effective? I currently use Qvar and Combivent. A. I am not familiar in any great detail about the benefits and risks of inhaled glutathione and whether it interacts with Qvar and Combivent.

I am a 75 year old male with mild to moderate COPD / Chronic Bronchitis. If I understand my condition, my breathing difficulty is due, in part, to the narrowing of my bronchial "tubes" due to scarring, over about 70 years of asthma attacks and acute bronchitis. If this is correct, would it be possible, in your opinion, to use laser surgery to vaporize/disappear the scar tissue? Lasers can be tuned to cut through steel as well as shave a micron off a cornea. Removal of scar tissue should be within its capabilities. I am not looking to you to authorize or encourage taking this approach to alleviating the condition. Only asking for your thoughts on the medical feasibility. I focus on natural ways to treat illness, this is not an area i have studied in any detail.